Although having a SMARCB1 or RB1 mutation appeared to be associated with increased odds of having a CDKN2Ahigh meningioma, these did not reach statistical significance and may be confounded by the relative rarity of RB1 mutations in meningiomas (Supplementary Fig. 9c). Here, SMARCB1 is linked to meningioma.